Xi Shi
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Treatment patterns and outcomes of second/third-line therapy in advanced non-small cell lung cancer with actionable genomic alterations (RECAP).
Journal: Clinical & experimental metastasis
Published: May 29, 2026
Treatment patterns and outcomes of later-line therapy in advanced non-small cell lung cancer with unknown or no actionable genomic alterations: a multicenter real-world study in China (RECAP study).
Journal: Translational lung cancer research
Published: March 30, 2026
Central amygdala HDAC6 contributes to visceral hypersensitivity and affective comorbidities in IBS-like rats.
Journal: International immunopharmacology
Published: January 20, 2026
Claudin 18.2-targeting antibody-drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial.
Journal: The Lancet. Oncology
Published: August 14, 2024
Prognostic biomarker CPEB3 and its associations with immune infiltration in clear cell renal cell carcinoma.
Journal: Biomedical reports
Published: September 01, 2023
A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancer.
Journal: Discover oncology
Published: July 31, 2023
Identification of a RAD51B enhancer variant for susceptibility and progression to glioma.
Journal: Cancer cell international
Published: February 26, 2023
Prophylaxis strategies containing high dose intravenous methotrexate on preventing CNS relapse for patients with diffuse large B-cell lymphoma at intermediate to high risk: A study based on 12 cohorts in the rituximab era.
Journal: International immunopharmacology
Published: July 29, 2022
Contribution of Amygdala Histone Acetylation in Early Life Stress-Induced Visceral Hypersensitivity and Emotional Comorbidity.
Journal: Frontiers in neuroscience
Published: December 25, 2021
An insertion variant of MGMT disrupts a STAT1 binding site and confers susceptibility to glioma.
Journal: Cancer cell international
Published: March 21, 2021
The landscape of kinase domain duplication in Chinese lung cancer patients.
Journal: Annals of translational medicine
Published: January 25, 2021
Apatinib plus Chemotherapy as a Second-Line Treatment in Unresectable Non-Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial.
Journal: The oncologist
Published: May 30, 2020
Last Updated: 09/26/2026